Evidence map›Paper›PMID 40918347›Full record

ArticleACS omega2025

Effect of Ipomoeassin F on the Synthesis of Membrane and Secretory Proteins in Triple-Negative Breast Cancer Cells.

Brihget Sicairos, Jianhong Zhou, Zhijian Hu, Qingyang Zhang, Wei Q Shi, Yuchun Du

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Brihget SicairosDepartment of Biological Sciences, University of Arkansas, Fayetteville, Arkansas 72701, United States.
Jianhong ZhouDepartment of Biological Sciences, University of Arkansas, Fayetteville, Arkansas 72701, United States.
Zhijian HuFeinstein Institute for Medical Research, Northwell Health, 350 Community Drive, Manhasset, New York 11030, United States.
Qingyang ZhangDepartment of Mathematical Sciences, University of Arkansas, Fayetteville, Arkansas 72701, United States.
Wei Q ShiDepartment of Chemistry, Ball State University, Muncie, Indiana 47306, United States.ORCID https://orcid.org/0000-0001-5453-1753
Yuchun DuDepartment of Biological Sciences, University of Arkansas, Fayetteville, Arkansas 72701, United States.ORCID https://orcid.org/0000-0001-9449-1274

Funding

Medicinal Chemistry and Chemical Proteomics of Ipomoeassin Natural GlycoresinsR15GM116032 · NIGMS · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI SHI, WEI · 2015 to 2020
$767k
NIGMS NIH HHS R15 GM116032
6 · The paper itself

Abstract

Ipomoeassin F (Ipom-F) is a natural compound that exhibits a potent cytotoxic effect on triple-negative breast cancer (TNBC) cells. The mechanism underlying this selective potency remains unclear. To elucidate this mechanism, we analyzed the proteome profiles of the TNBC MDA-MB-231 cells after exposure to Ipom-F at different time points and increasing doses using a quantitative proteomic method. Our proteomic data demonstrate that the major effect of Ipom-F on MDA-MB-231 cells is the inhibition of membrane and secreted protein expression. These findings align with the recently uncovered molecular mechanism of action of Ipom-F, which binds to Sec61-α and inhibits the cotranslational import of proteins into the endoplasmic reticulum. We have defined a subset of membrane and secreted proteins particularly sensitive to Ipom-F. Analysis of the expression of these Ipom-F-sensitive proteins in cancer cell lines and breast cancer tissues reveals that some of these proteins are upregulated in TNBC cells. This suggests that TNBC cells may have adapted to the elevated levels of these proteins, making them more dependent on their expression. Consequently, inhibiting these proteins leads to a crisis in proliferation and/or survival. Additionally, our data suggests that Ipom-F may act as an immunosuppressive agent.

Identifiers

PMID40918347
PMCPMC12409539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.